Deutsche Bank AG Makes New Investment in Danaher Corporation $DHR

Deutsche Bank AG purchased a new stake in shares of Danaher Corporation (NYSE:DHR) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 721,796 shares of the conglomerate’s stock, valued at approximately $519,722,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in DHR. Bell Investment Advisors Inc purchased a new position in shares of Danaher in the second quarter worth approximately $47,000. State of Wyoming bought a new stake in shares of Danaher during the 2nd quarter valued at $74,000. Elevated Capital Advisors LLC purchased a new stake in shares of Danaher in the 4th quarter worth $26,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Danaher in the 4th quarter worth $27,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its holdings in Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 53 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.0%

Shares of Danaher stock opened at $202.44 on Tuesday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company has a market capitalization of $142.31 billion, a P/E ratio of 35.96, a P/E/G ratio of 2.52 and a beta of 0.78. The company has a fifty day moving average of $193.52 and a 200 day moving average of $192.67.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the firm earned $0.77 earnings per share. The business’s quarterly revenue was up 5.5% on a year-over-year basis. On average, sell-side analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on DHR shares. Argus lowered their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Royal Bank Of Canada upped their price target on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. Morgan Stanley decreased their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Jefferies Financial Group reaffirmed a “buy” rating and set a $245.00 price objective on shares of Danaher in a research report on Tuesday, April 21st. Finally, Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.